Economic costs of nonmedical use of prescription opioids

Clinical Journal of Pain

Volumn 27, Issue 3, 2011, Pages 194-202

  Hansen, Ryan N ^a   Oster, Gerry ^b   Edelsberg, John ^b   Woody, George E ^c   Sullivan, Sean D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b POLICY ANALYSIS INC PAI   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

abuse; nonmedical opioid use; opiates; oxycodone; prescription opioid misuse

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; METHADONE; MORPHINE; OXYCODONE; PETHIDINE; PRESCRIPTION DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COST BENEFIT ANALYSIS; CRIMINAL JUSTICE; DRUG ABUSE; HEPATITIS C; HUMAN; NEWBORN CARE; PRIORITY JOURNAL; UNITED STATES;

EID: 79951675101     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181ff04ca     Document Type: Article

References (37)

1. Compton W, Volkow N. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alocohol Depend. 2006;81:103-107. (Pubitemid 41821793)
2. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS data brief, no. 22. Hyattsville, MD: National Center for Health Statistics; 2009. Available at www.cdc.gov/nchs/data/databriefs/db22.pdf. [Accessed August 5, 2010].
3. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results from the 2006 National Survey on Drug Use and Health. 2007. National Findings (Office of Applied Studies), NSDUH Series: H-32, DHHS Publication No. (SMA) 07-4293. Rockville, MD, 2007.
4. Birnbaum HG, White AG, Reynolds JL, et al. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective. Clin J Pain. 2006;22:667-676. (Pubitemid 44434948)
5. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2004 [Computer file]. ICPSR04373-v1. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2006-05-12.
6. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2005 [Computer file]. ICPSR04596-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2009-08-12.
7. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2006 [Computer file]. ICPSR21240-v4. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2009-08-12.
8. Mark TL, Levit KR, Coffey RM, et al. National Expenditures for Mental Health Services and Substance Abuse Treatment, 1993-2003. Rockville, MD: Substance Abuse and Mental Health Services Administration, SAMHSA Publication No. (SMA) 07-4227; 2007.
9. Department of Labor. Bureau of Labor Statistics. 2008. Available at: http://www.bls.gov. [Accessed August 5, 2010].
10. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. New Engl J Med. 1998;339:1897-1904. (Pubitemid 29013934)
11. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. National HIV Prevention Conference. 2005. Available at: http://www.aegis.com/conferences/NHIVPC/2005/T1-B1101.html. [Accessed August 5, 2010].
12. Centers for Disease Control (CDC) and Prevention. HIV/AIDS Surveillance Report, 2006. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention website. 2008. Available at: http://www.cdc.gov/hiv/ topics/surveillance/resources/reports. [Accessed August 5, 2010].
13. Census Bureau. The 2008 Statistical Abstract: The National Databook. Table 120 Deaths-Life years lost and mortality costs by age, sex, and cause. 2008. Available at: http://www.census.gov/compendia/statab/cats/births-deaths- marriages-divorces.html. [Accessed August 5, 2010].
14. Leigh JP, Bowlus CL, Leistikow BN, et al. Costs of hepatitis C. Arch Int Med. 2001;161:2231-2237. (Pubitemid 32905004)
15. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Int Med. 2006;144:705-714.
16. Wasley A, Grytdal S, Gallagher K. Surveillance for acute viral hepatitis-United States, 2006. Centers for Disease Control (CDC) and Prevention website. 2008. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5702a1. htm. [Accessed August 5, 2010].
17. HCUP Kids' Inpatient Database (KID). Healthcare Cost and Utilization Project (HCUP). 2000 and 2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/kidoverview.jsp.
18. Haddix AC, Teutsch SM, Corso PS. (eds). Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. US: Oxford University Press; 2002.
19. Centers for Disease Control (CDC) and Prevention. Wonder online database: Mortality-underlying cause of death. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention website. 2005. Available at: http://wonder.cdc.gov/. [Accessed June 16, 2008].
20. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Safety. 2006;15:618-627. (Pubitemid 44404658)
21. Paulozzi LJ, Ryan G. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prevent Med. 2006;31:506-511. (Pubitemid 44880582)
22. Office of National Drug Control Policy. The Economic Costs of Drug Abuse in the United States: 1992-1998. Washington, DC: Executive Office of the President (Publication No. NCJ-190636); 2001.
23. Department of Labor. Bureau of Labor Statistics. Annual indexes of productivity, hourly compensation, unit costs, and prices. 2007. Available at: http://www.bls.gov/news.release/prod2.t14.htm. [Accessed August 5, 2010].
24. Department of Justice. Office of Justice Programs, Bureau of Justice Statistics. Prison and jail inmates at midyear 2006. 2007. Available at: http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=1006. [Accessed August 5, 2010].
25. Department of Justice. Office of Justice Programs, Bureau of Justice Statistics. Profile of jail inmates, 2002. 2004. Available at: http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=1118. [Accessed August 5, 2010].
26. Harwood H, Fountain D, Livermore G. The Economic Costs of Alcohol and Drug Abuse in the United States 1992. Rockville, MD: National Institutes on Drug Abuse; 1998.
27. Department of Justice. Office of Justice Programs, Bureau of Justice Statistics. Prisoners in 2006. 2007. Available at: http://bjs.ojp.usdoj.gov/ index.cfm?ty=pbdetail&iid=908. [Accessed August 5, 2010].
28. Department of Justice. Office of Justice Programs, Bureau of Justice Statistics. Justice expenditure and employment in the United States, 2003. 2006. Available at: http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=1017. [Accessed August 5, 2010].
29. Department of Justice. Federal Bureau of Investigation. Uniform crime statistics - Estimated number of arrests. 2006. Available at: http://www.fbi.gov/ucr/cius2006/data/table-29.html. [Accessed August 5, 2010].
30. Miller TR, Levy DT, Cohen MA, et al. Costs of alcohol and drug-involved crime. Prev Sci. 2006;7:333-342. (Pubitemid 44915084)
31. Cawley J. The cost-effectiveness of programs to prevent or reduce obesity the state of the literature and a future research agenda. Arch Pediatr Adolesc Med. 2007;161:611-614. (Pubitemid 46878691)
32. Smoking and tobacco use: MMWRs: 2002: Annual smoking-attributable mortality, years of potential life lost, and economic costs: Office on smoking and health (OSH): CDC [homepage on the Internet]. [cited 9/29/2009]. Available at: http://www.cdc.gov/tobacco/data-statistics/mmwrs/byyear/2002/mm5114a2/ highlights.htm.
33. Tenth Special Report to Congress on Alcohol and Health from The Secretary of Health and Human Services. DHHS Publication. June 2000;No. 00-1583.
34. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
35. Woody GE, Poole S, Subramaniam G, et al. Extended versus short-term buprenorphine-naloxone for treatment of opioid addicted youth: a randomized trial. J Am Med Assoc. 2008;300:2002-2011.
36. Subramaniam GA, Stitzer ML, Woody G, et al. Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders. Drug Alcohol Depend. 2009;99:141-149.
37. Polsky D, Glick HA, Yang J, et al. Cost-effectiveness of extended buprenorphine-naloxone treatment for opioidad-dicted youth. Data from a Randomized Trial. 2010;105:1616-1624.